Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives

Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives

Prostate cancer therapy for locally advanced and metastatic diseases includes androgen deprivation therapy (ADT). Second-generation antiandrogens have a role in castration-resistant prostate cancer. Nevertheless, some patients do not respond to this therapy, and eventually all the patients became re...

Full description

Bibliographic Details
Main Authors: Francesco Pinto, Francesco Dibitetto, Mauro Ragonese, Pierfrancesco Bassi
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Medical Sciences
Subjects:
prostatecancer
abiraterone
enzalutamide
apalutamide
darolutamide
castrationresistance
Online Access:https://www.mdpi.com/2076-3271/10/2/25

Internet

https://www.mdpi.com/2076-3271/10/2/25

Similar Items